Mihail Obrocea
2021
In 2021, Mihail Obrocea earned a total compensation of $2.1M as Chief Medical Officer at MAIA Biotechnology.
Compensation breakdown
| Bonus | $57,731 |
|---|---|
| Option Awards | $1,907,411 |
| Salary | $162,500 |
| Other | $18,344 |
| Total | $2,145,986 |
Obrocea received $1.9M in option awards, accounting for 89% of the total pay in 2021.
Obrocea also received $57.7K in bonus, $162.5K in salary and $18.3K in other compensation.
Rankings
In 2021, Mihail Obrocea's compensation ranked 5,786th out of 12,406 executives tracked by ExecPay. In other words, Obrocea earned more than 53.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,786 out of 12,406 | 53rd |
Division Manufacturing | 2,451 out of 5,492 | 55th |
Major group Chemicals And Allied Products | 1,062 out of 2,368 | 55th |
Industry group Drugs | 945 out of 2,089 | 55th |
Industry Pharmaceutical Preparations | 678 out of 1,536 | 56th |
Source: SEC filing on April 19, 2023.
Obrocea's colleagues
We found three more compensation records of executives who worked with Mihail Obrocea at MAIA Biotechnology in 2021.